Tag: TGA (Therapeutic Goods Administration)

While a new Melbourne trial finds psilocybin-assisted therapy beneficial for the mental health of terminally ill patients, Australia’s broader experiment with medical psychedelics faces challenges. Our analysis raises concerns over a patchwork of regulations, unlawful promotion, and the potential for patient harm, and urging improvements to the authorised prescriber scheme.